Predicting sentinel lymph node metastases in infiltrating breast carcinoma with vascular invasion

International Journal of Surgical Pathology

Volumn 14, Issue 4, 2006, Pages 306-311

  Jonjić, Nives ^a   Mustać, Elvira ^a   Dekanić, Andrea ^a   Marijić, Blažen ^a   Gašpar, Božena ^a   Kolić, Ivana ^a   Čoklo, Miran ^a   Sasso, Franco ^b  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b University Department of Surgery   (Italy)

Author keywords

Breast neoplasm; Lymphovascular invasion; Sentinel lymph node

Indexed keywords

CYTOKERATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; STEROID RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER INVASION; CANCER STAGING; CELL INFILTRATION; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENTINEL LYMPH NODE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD31; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATINS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; SENTINEL LYMPH NODE BIOPSY;

EID: 33749599122     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/1066896906293054     Document Type: Article

References (33)

1. Dees EC, Shulman LN, Souba WW, et al. Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection. Ann Surg. 1997;226:279-286.
2. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma. Cancer. 1997;80:1188-1197.
3. Rampaul R, Miremadi A, Pinder S, et al. Pathological validation of significance of micrometastasis in sentinel nodes in primary breast cancer. Breast Cancer Res. 2001;3:113-116.
4. Trocha SD, Giuliano AE. Sentinel node in the era of neoadjuvant therapy and locally advanced breast cancer. Surg Oncol. 2003;12:271-276.
5. Dawson PJ, Ferguson DJ, Karrison T. The pathologic findings of breast cancer in patients surviving 25 years after radical mastectomy. Cancer. 1982;50:2131-2138.
6. Pinder S, Ellis IO, O'Rourke S, et al. Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large series with long-term follow-up. Histopathology. 1994;24:41-47.
7. Hunt JL, Baloch ZW, LiVolsi VA. Sentinel lymph node evaluation for tumor metastasis. Semin Diagn Pathol. 2002;19:263-277.
8. Schwartz GF, Giuliano AE, Veronesi U, Consensus Conference Committee. Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast. April 19-22, 2001, Philadelphia, Pennsylvania. Hum Pathol. 2002;33:579-589.
9. Zerwes FP, Frasson AL, Gutfilen B, Barbosa da Fonseca LM. Identification of sentinel node in breast cancer. J Exp Clin Cancer Res. 2002;21:155-158.
10. Pargaonkar AS, Beissner RS, Snyder S, Speights VO. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Arch Pathol Lab Med. 2003;127:701-705.
11. Pelosi E, Arena V, Baudino B, et al. Sentinel node detection in breast carcinoma. Tumori. 2002;88:110-111.
12. Turner RR, Chu KU, Qi K, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer. 2000;89:574-581.
13. Harden SP, Neal AJ, Al-Nasiri N, Ashley S, Querci della Rovere G. Predicting axillary lymph node metastases in patients with T1 infiltrative ductal carcinoma of the breast. Breast. 2001;10:155-159.
14. Choi SH, Barsky SH, Chang HR. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer. Breast J. 2003;9:153-162.
15. Ying C, Paner GP, Rajan PB. Sentinel node status and tumor characteristics. Arch Pathol Lab Med. 2005;129:82-84.
16. Viale G, Zurrida S, Maiorono E, et al. Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer. 2005;103:492-500.
17. D'Errico A, Grassigli A, Gruppioni E, et al. Thorough intraoperative analysis of breast sentinel lymph node biopsies: histologic and immunohistochemical findings. Surgery. 2004;135:248-254.
18. Elston CW, Ellis IO, eds. The Breast. 3rd ed. New York, NY: Churchill Livingstone; 1998.
19. Rosen PP. Rosen's Breast Pathology. 2nd ed. Baltimore, Md: Lippincott Williams & Wilkins; 2001.
20. Carter BA, Page DL. Sentinel lymph node histopathology in breast cancer: minimal disease versus artifact. J Clin Oncol. 2006;24:1978-1979.
21. Bleiweiss I, Nagi C, Jaffer S. Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol 2006;24:2013-2018.
22. Van Zee KJ, Manasseh DME, Bevilacqua JLB, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003;10:1140-1151.
23. Weiser MR, Montgomery LL, Susnik B, et al. Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile? Ann Surg Oncol. 2000;7:651-655.
24. Shiver SA, Creager AJ, Geisinger K, Perrier ND, Shen P, Levine EA. Intraoperative analysis of sentinel lymph nodes by imprint cytology for cancer of the breast. Am J Surg. 2002;184:424-427.
25. Suer T, Engh V, Holck AM, et al. Imprint cytology of sentinel lymph nodes in breast cancer. Experience with rapid, intraoperative diagnosis and primary screening by cytotechnologists. Acta Cytol. 2003;47:768-773.
26. Creager AJ, Geisniger KR, Perrier ND, et al. Intraoperative imprint cytologic evaluation of sentinel lymph node for lobular carcinoma of the breast. Ann Surg. 2004;239:61-66.
27. Menes TS, Tartter PI, Mizrachi H, Smith SR, Estabrook A. Touch preparation or frozen section for intraoperative detection of sentinel lymph node metastases from breast cancer. Ann Surg Oncol. 2003;10:1166-1170.
28. Dowlatshani K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma. Cancer. 1997;80:1188-1197.
29. Cohen C, Alazraki N, Styblo T, Waldrop SM, Grant SF, Larsen T. Immunohistochemical evaluation of sentinel lymph nodes in breast carcinoma patients. Appl Immunohistochem Mol Morphol. 2002;10:296-303.
30. Inokuchi M, Ninomiya I, Tsugawa K, Terada I, Miwa K. Quantitative evaluation of metastases in axillary lymph nodes of breast cancer. Br J Cancer. 2003;89:1750-1756.
31. Schroder CP, Ruiters MH, de Jong S, et al. Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes. Int J Cancer. 2003;10:611-618.
32. Stitzenberg KB, Calvo BF, Iacocca MV, et al. Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer. Am J Clin Pathol. 2002;117:729-737.
33. Imoto S, Wada N, Murakami K, Hasebe T, Ochiai A, Ebihara S. Prognosis of breast cancer patients treated with sentinel node biopsy in Japan. Jpn J Clin Oncol. 2004;34:452-456.